Mary Ann Liebert Inc.: Current Challenges and Next Steps in Treating Pediatric Acute Respiratory Distress Syndrome
July 30, 2019
July 30, 2019
NEW ROCHELLE, New York, July 30 -- Mary Ann Liebert Inc. issued the following news release, dated July 26:
A new review of Pediatric Acute Respiratory Distress Syndrome (PARDS) highlights the lack of data available for standard treatment approaches and adjunctive therapies, leading to significant variability in patient management. This comprehensive review article, which also identifies a great need for studies to generate outcomes data in pediatric patients with ARDS, is published . . .
A new review of Pediatric Acute Respiratory Distress Syndrome (PARDS) highlights the lack of data available for standard treatment approaches and adjunctive therapies, leading to significant variability in patient management. This comprehensive review article, which also identifies a great need for studies to generate outcomes data in pediatric patients with ARDS, is published . . .